Dr. Verena Murphy

Dr. Verena Murphy

Head of Research and Business Development in Cancer Trials Ireland

Dr Verena Murphy is the Head of Research and Business Development in Cancer Trials Ireland. She has a PhD in Biochemistry from the University of Zurich, Switzerland, and worked at a variety of academic and clinical research laboratories in Germany, Switzerland, Canada, and Ireland with a focus on cancer research. In Nov 2009, she took up a position as Translational Research Coordinator in the All-Ireland Cooperative Oncology Research Group (ICORG), today Cancer Trials Ireland, a charity focused on academic clinical trials in cancer.

In 2015, she became Clinical Programme Leader, and in 2017 Translational Research Leader, working on the oversight and execution of operational strategies for multiple programs in the oncology portfolio. Since 2015 she is a member of the leadership team and involved in the development of new strategic directions and programs. Verena was promoted to Head of Research and Business Development in 2019 and became the main contact point for academic cancer researchers, academic collaborative trials groups, and external stakeholders, e.g. the Health Research Board, the Irish Cancer Society, and industry. Together with senior management she developed the several successful grant applications and brought funding of over €9,9M over 5 years to Cancer Trials Ireland.

 

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Contact Us

Contact Us
Irish Association for Cancer Research
9A Coolkill, Sandyford, Dublin 18

T: +353 (0)1 295 8859
E: info@iacr.ie

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.

Registered Charity Number (RCN): 20030117

Design by patterns.ie
© 2022